#271 - AMA #51: Understanding and improving your metabolic health
In this AMA #51 sneak peek, host Peter Attia and Nick Stenson discuss metabolic disease, its link to the "four horsemen" of aging, and various metrics Peter uses to assess metabolic health beyond common tests.
Deep Dive Analysis
9 Topic Outline
Introduction to AMA #51 and Metabolic Disease Focus
Defining Metabolic Disease and its Connection to Other Chronic Illnesses
Historical Context: Dr. Jerry Reaven and Syndrome X
Diagnostic Criteria for Metabolic Syndrome
Quantitative Impact of Metabolic Syndrome on Chronic Diseases
Metabolic Syndrome's Link to Cancer and Neurodegenerative Diseases
Limitations of Body Weight and BMI in Assessing Metabolic Health
Comprehensive Metrics for Individual Metabolic Health Assessment
Overview of Traditional and Functional Biomarkers, Imaging Studies
4 Key Concepts
Four Horsemen of Aging
These are the major disease processes of aging: cardiovascular disease, cancer, neurodegenerative disease, and metabolic disease. Peter Attia emphasizes that metabolic disease is a continuum of conditions that feeds into the other three.
Syndrome X (Metabolic Syndrome)
Originally identified by endocrinologist Jerry Reaven in the 1980s, Syndrome X (now metabolic syndrome) is a cluster of five signs: truncal obesity, elevated triglycerides, depressed HDL cholesterol, elevated blood pressure, and elevated glucose levels. It was observed to be a remarkable predictor of chronic diseases of aging.
Metabolic Syndrome Diagnostic Criteria
Metabolic syndrome is defined by having three or more of the following: waist circumference >40 inches (men) or >35 inches (women), triglycerides >150 mg/dL, HDL cholesterol <40 mg/dL (men) or <50 mg/dL (women), blood pressure >130/85 (or on medication), and fasting glucose >100 mg/dL.
Reverse Causality
This refers to a situation where an outcome, such as having Alzheimer's disease, might actually lead to a risk factor, like abdominal obesity, rather than the risk factor causing the outcome. This can sometimes make statistical associations appear counterintuitive.
4 Questions Answered
The four major disease processes of aging are cardiovascular disease, cancer, neurodegenerative disease, and metabolic disease, which is a continuum of conditions.
Metabolic syndrome significantly increases the risk of all-cause mortality, cardiovascular mortality, cancer mortality and incidence (especially certain cancers like endometrial, esophageal, gastric, liver, and kidney), and neurodegenerative diseases such as Parkinson's and vascular dementia.
Body weight and BMI are crude tools, useful for population-level health indicators but not for individual assessment because they don't account for body composition or insulin sensitivity. A significant portion of metabolically unhealthy individuals are not obese by BMI criteria.
Peter Attia categorizes metrics into functional tests (e.g., resting/fasting lactate, Zone 2 output, CPET, oral glucose tolerance tests, continuous glucose monitoring), imaging tests (e.g., DEXA scans for visceral adipose tissue and muscle mass, liver ultrasound), and traditional blood-based biomarkers (e.g., uric acid, homocysteine, triglycerides, HDL, fasting glucose, insulin, hemoglobin A1c, and liver function tests).
5 Actionable Insights
1. Understand Metabolic Syndrome Markers
Regularly assess the five signs of metabolic syndrome—truncal obesity (waist circumference >40 inches men, >35 inches women), elevated triglycerides (>150 mg/dL), depressed HDL (<40 mg/dL men, <50 mg/dL women), elevated blood pressure (>130/85 mmHg or on medication), and elevated fasting glucose (>100 mg/dL)—and their specific thresholds, aiming to have none of these risk factors for optimal health.
2. Prioritize DEXA Scans
Opt for DEXA scans to measure visceral adipose tissue, muscle mass, and overall body fat, as this provides a more accurate and relevant assessment of metabolic health compared to the crude tools of body weight and BMI.
3. Monitor Advanced Blood Biomarkers
Beyond standard annual physicals, track a comprehensive set of blood-based biomarkers including uric acid, homocysteine, insulin, hemoglobin A1c, liver function tests, and resting/fasting lactate levels to gain a nuanced understanding of individual metabolic health.
4. Employ Functional Metabolic Testing
Utilize advanced functional tests such as zone two output, CPET testing (for oxygen and CO2 utilization under stress), oral glucose tolerance tests, and continuous glucose monitoring to evaluate metabolic health dynamically and in response to physiological demands.
5. Assess Liver Health
Investigate liver health using ultrasound combined with blood tests and algorithms to determine fibrosis scores, which are crucial for understanding the prevalence and impact of fatty liver disease on overall metabolic health.
5 Key Quotes
Smoking is an enormous driver of risk for cancer, it is, it remains the number one environmental trigger of cancer, but obesity is number two.
Peter Attia
It's such a crude tool, it's understandable why body weight and BMI are used as health indicators at the population level, you know you're stuck with things that are very simple and reliable.
Peter Attia
I don't know the BMI of one of my patients and I don't care because I'm not trying to practice medicine on a population basis.
Peter Attia
In an ideal world you wouldn't want to have any of these things.
Peter Attia
Metabolic disease which is really a continuum of conditions.
Peter Attia